NCT03688815

Brief Summary

Analysis of certain biomarkers and transient myocardial perfusion deficit revealed by myocardial perfusion scintigraphy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2010

Completed
7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

September 25, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 28, 2018

Completed
Last Updated

September 28, 2018

Status Verified

September 1, 2018

Enrollment Period

1 year

First QC Date

September 25, 2018

Last Update Submit

September 27, 2018

Conditions

Ischemic Heart DiseaseIschemic Attack

Outcome Measures

Primary Outcomes (1)

  • Myocardial perfusion abnormality

    Myocardial perfusion was quantified based on myocardial perfusion scintigraphy (MPS).

    5 year follow-up after MPS

Study Arms (1)

Patients with ischemic heart disease

Patients with ischemic heart disease scheduled for myocardial perfusion scintigraphy were enrolled. Biomarkers were analysed form periferal blood. Patients outcome data were followed up to 5 years.

Diagnostic Test: myocardial perfusion scintigraphy

Interventions

myocardial perfusion scintigraphyDIAGNOSTIC_TEST

Myocardial perfusion scintigraphy as it is described in the international literature.

Patients with ischemic heart disease

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive patients with IHD were enrolled.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pecs

Pécs, Baranya, 7624, Hungary

Location

Related Publications (1)

  • Molnar T, Horvath A, Szabo Z, Vamos Z, Doczi T, Illes Z. Detection of silent cerebral microcirculatory abnormalities in patients with manifest ischemic coronary disease: a perfusion brain MRI study combined with dipyridamole stress. Scand Cardiovasc J. 2021 Apr;55(2):97-101. doi: 10.1080/14017431.2020.1821911. Epub 2020 Sep 18.

    PMID: 32945202DERIVED

Related Links

MeSH Terms

Conditions

Myocardial Ischemia

Interventions

Myocardial Perfusion Imaging

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Cardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisPerfusion ImagingRadionuclide ImagingHeart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques, Radioisotope

Study Officials

  • Tihamer Molnar, MD

    University of Pecs

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

September 25, 2018

First Posted

September 28, 2018

Study Start

January 1, 2009

Primary Completion

January 1, 2010

Study Completion

January 1, 2017

Last Updated

September 28, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share

IPD sharing plan: publication of data in a peer-reviewed journal

Locations

HU(1)